These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12630350)

  • 1. [Molecular biological monitoring of the polioviruses circulation in Belarus].
    Beletskaia TS; Fel'dman EV; Samoĭlovich EO; Scheslenok EP; Kapustik LA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):29-36. PubMed ID: 12630350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutation and recombination variability of vaccine polioviruses isolated in Belarus (1960-1999)].
    Beletskaia TS; Samoĭlovich EO; Korotkova EA; Scheslenok EP; Fel'dman EV
    Mol Gen Mikrobiol Virusol; 2002; (1):24-31. PubMed ID: 11904921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages.
    Savolainen-Kopra C; Samoilovich E; Kahelin H; Hiekka AK; Hovi T; Roivainen M
    J Gen Virol; 2009 Aug; 90(Pt 8):1859-1868. PubMed ID: 19403755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
    Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
    J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic recombination in wild-type poliovirus.
    Dahourou G; Guillot S; Le Gall O; Crainic R
    J Gen Virol; 2002 Dec; 83(Pt 12):3103-3110. PubMed ID: 12466487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
    Arita M; Zhu SL; Yoshida H; Yoneyama T; Miyamura T; Shimizu H
    J Virol; 2005 Oct; 79(20):12650-7. PubMed ID: 16188967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
    Guillot S; Caro V; Cuervo N; Korotkova E; Combiescu M; Persu A; Aubert-Combiescu A; Delpeyroux F; Crainic R
    J Virol; 2000 Sep; 74(18):8434-43. PubMed ID: 10954543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic variability of Poliovirus: typing of strains isolated in Madagascar by restriction fragment length polymorphism (RFLP) assay].
    Razafindratsimandresy R; Rakoto Andrianarivelo M; Rousset D
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):27-32. PubMed ID: 15678812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
    Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
    Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
    Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
    Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses.
    Boot HJ; Schepp RM; van Nunen FJ; Kimman TG
    J Virol Methods; 2004 Mar; 116(1):35-43. PubMed ID: 14715305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
    J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild poliovirus circulation among healthy children immunized with oral polio vaccine in Antananarivo, Madagascar.
    Andrianarivelo MR; Rabarijaona L; Boisier P; Chezzi C; Zeller HG
    Trop Med Int Health; 1999 Jan; 4(1):50-7. PubMed ID: 10203174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
    Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
    Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Bianchi FP; Larocca AMV; Bozzi A; Spinelli G; Germinario CA; Tafuri S; Stefanizzi P
    Vaccine; 2021 May; 39(22):2989-2994. PubMed ID: 33933314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.